T2 Biosystems to Participate in the SVB Leerink Global Healthcare Conference
February 19 2020 - 4:05PM
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid
detection of sepsis-causing pathogens, today announced that the
Company plans to participate in the upcoming SVB Leerink Global
Healthcare Conference in New York, New York.
Management is scheduled to present Thursday, February 27, 2020
at 11:00am ET. Interested parties may access a live and recorded
webcast of the presentation on the “Investors” section of the
company’s website at www.t2biosystems.com.
About T2 Biosystems T2 Biosystems, a
leader in the rapid detection of sepsis-causing pathogens, is
dedicated to improving patient care and reducing the cost of care
by helping clinicians effectively treat patients faster than ever
before. T2 Biosystems’ products include the T2Dx® Instrument,
T2Candida® Panel, the T2Bacteria® Panel, and the
T2Resistance™ Panel and are powered by the proprietary T2
Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active
pipeline of future products, including products for the detection
of additional species and antibiotic resistance markers of sepsis
pathogens, and tests for Lyme disease.
Media Contact: Gina Kent, Vault
Communications gkent@vaultcommunications.com 610-455-2763
Investor Contact: Philip Trip Taylor, Gilmartin
Group philip@gilmartinIR.com 415-937-5406
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Aug 2024 to Sep 2024
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Sep 2023 to Sep 2024